IL1B and metabolic dysfunction-associated steatohepatitis: IL-1β mRNA was significantly induced in patients with steatosis or NASH compared to healthy controls (Fig. 1G) but IL-1β expression was 20% lower in NASH livers compared to steatosis livers.